FDA 483 - Laurus Synthesis Private Limited

An FDA inspection of Laurus Synthesis Private Limited, an API Intermediate Manufacturer in Anakapalli, India, revealed significant deficiencies across multiple areas. The firm was cited for inadequate investigations into unexpected occurrences, insufficient sampling plans for intermediates, and poor equipment maintenance and cleaning practices. Additionally, issues were noted with incomplete batch production records and uncontrolled issuance of critical documents, indicating a need for comprehensive quality system improvements.